Hunneyball I M, Crossley M J, Spowage M
Agents Actions. 1986 Jun;18(3-4):394-400. doi: 10.1007/BF01965003.
The effects of treatment with second-line antirheumatic drugs and cytotoxic agents on the severity of experimental monoarticular arthritis in BALB/c mice have been investigated. The arthritis was assessed histologically in terms of synovitis and erosions of cartilage and bone. Azathioprine (20 mg/kg) and sulphasalazine (10-30 mg/kg oral; 30-100 mg/kg i.p.) produced significant suppression of synovitis and erosions when administered daily for 4 weeks commencing 2 weeks after induction of the arthritis. Dapsone (1-10 mg/kg) and to a lesser extent methotrexate (2 mg/kg) produced some suppression of erosive disease when administered daily for 4 weeks commencing 2 weeks after induction of the arthritis but this failed to reach statistical significance. Chloroquine, D-penicillamine and sodium aurothiomalate all failed to have any effect on the disease with any of the treatment schedules used. Auranofin had no effect on the disease when treatment commenced 2 weeks after intra-articular injection but produced variable suppression at high doses when administered from the day of intra-articular injection.
已研究二线抗风湿药物和细胞毒性药物治疗对BALB/c小鼠实验性单关节炎严重程度的影响。通过组织学评估关节炎的滑膜炎以及软骨和骨侵蚀情况。硫唑嘌呤(20毫克/千克)和柳氮磺胺吡啶(口服10 - 30毫克/千克;腹腔注射30 - 100毫克/千克)在关节炎诱导2周后开始每日给药4周,可显著抑制滑膜炎和侵蚀。氨苯砜(1 - 10毫克/千克)以及程度较轻的甲氨蝶呤(2毫克/千克)在关节炎诱导2周后开始每日给药4周,可对侵蚀性疾病产生一定抑制作用,但未达到统计学显著性。氯喹、D - 青霉胺和金硫代苹果酸钠在使用的任何治疗方案下对该疾病均无任何作用。从关节内注射后2周开始治疗时,金诺芬对该疾病无作用,但从关节内注射当天开始给药时,高剂量可产生不同程度的抑制作用。